These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17714057)

  • 1. The prevalence of pantoprozole associated thrombocytopenia in a community hospital.
    Dotan E; Katz R; Bratcher J; Wasserman C; Liebman M; Panagopoulos G; Spaccavento C
    Expert Opin Pharmacother; 2007 Sep; 8(13):2025-8. PubMed ID: 17714057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pantoprazole-induced thrombocytopenia in patients with upper gastrointestinal bleeding.
    Binnetoğlu E; Akbal E; Şen H; Güneş F; Erbağ G; Aşık M; Bozkurt N; Uludağ A; Tekin M; Tekin SZ
    Platelets; 2015; 26(1):10-2. PubMed ID: 24512269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pantoprazole-induced thrombocytopenia.
    Watson TD; Stark JE; Vesta KS
    Ann Pharmacother; 2006 Apr; 40(4):758-61. PubMed ID: 16569810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombocytopenia as a side effect of pantoprazole.
    Taş A
    Turk J Gastroenterol; 2013; 24(3):295-6. PubMed ID: 24226727
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of cytopenia in geriatric inpatients.
    Röhrig G; Becker I; Pappas K; Polidori MC; Schulz RJ
    Z Gerontol Geriatr; 2018 Feb; 51(2):231-236. PubMed ID: 28660533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nosocomial pneumonia risk and stress ulcer prophylaxis: a comparison of pantoprazole vs ranitidine in cardiothoracic surgery patients.
    Miano TA; Reichert MG; Houle TT; MacGregor DA; Kincaid EH; Bowton DL
    Chest; 2009 Aug; 136(2):440-447. PubMed ID: 19318661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study.
    Ray WA; Murray KT; Griffin MR; Chung CP; Smalley WE; Hall K; Daugherty JR; Kaltenbach LA; Stein CM
    Ann Intern Med; 2010 Mar; 152(6):337-45. PubMed ID: 20231564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pantoprazole: a proton pump inhibitor with oral and intravenous formulations.
    Devault KR
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):197-205. PubMed ID: 19072410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump induced thrombocytopenia: A case report and review of literature.
    Kallam A; Singla A; Silberstein P
    Platelets; 2015; 26(6):598-601. PubMed ID: 25207666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pantoprazole-induced thrombocytopenia.
    Miller JL; Gormley AK; Johnson PN
    Indian J Pediatr; 2009 Dec; 76(12):1278-9. PubMed ID: 20012806
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk of gastric cancer, gastrointestinal cancers and other cancers: a comparison of treatment with pantoprazole and other proton pump inhibitors.
    Schneider JL; Kolitsopoulos F; Corley DA
    Aliment Pharmacol Ther; 2016 Jan; 43(1):73-82. PubMed ID: 26541643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of peptic ulcer bleeding following treatment with proton pump inhibitors in routine clinical practice: 935 patients with high- or low-risk stigmata.
    Lanas A; Carrera-Lasfuentes P; García-Rodríguez LA; García S; Arroyo-Villarino MT; Ponce J; Bujanda L; Calleja JL; Polo-Tomas M; Calvet X; Feu F; Perez-Aisa A
    Scand J Gastroenterol; 2014 Oct; 49(10):1181-90. PubMed ID: 25144754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence of rebleeding from peptic ulcer in patients treated with proton pump inhibitors].
    Garrido A; Iborra MI; Saperas E; de Sousa M;
    Med Clin (Barc); 2010 May; 134(13):577-82. PubMed ID: 20189198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lansoprazole-Induced Thrombocytopenia in a Critically Ill Patient: A Case Report.
    Saad M; Mitwally H
    J Pharm Pract; 2020 Oct; 33(5):700-704. PubMed ID: 30917722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term, open-label trial: safety and efficacy of continuous maintenance treatment with pantoprazole for up to 15 years in severe acid-peptic disease.
    Brunner G; Athmann C; Schneider A
    Aliment Pharmacol Ther; 2012 Jul; 36(1):37-47. PubMed ID: 22531114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy.
    Niwa T; Suzuki A; Sakakibara S; Kasahara S; Yasuda M; Fukao A; Matsuura K; Goto C; Murakami N; Itoh Y
    Clin Ther; 2009 Oct; 31(10):2126-33. PubMed ID: 19922883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial of high dose bolus versus continuous intravenous infusion pantoprazole as an adjunct therapy to therapeutic endoscopy in massive bleeding peptic ulcer.
    Yamada S; Wongwanakul P
    J Med Assoc Thai; 2012 Mar; 95(3):349-57. PubMed ID: 22550833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative risk of ischemic stroke among users of clopidogrel together with individual proton pump inhibitors.
    Leonard CE; Bilker WB; Brensinger CM; Flockhart DA; Freeman CP; Kasner SE; Kimmel SE; Hennessy S
    Stroke; 2015 Mar; 46(3):722-31. PubMed ID: 25657176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole.
    Holtmann G; Cain C; Malfertheiner P
    Gastroenterology; 1999 Jul; 117(1):11-6. PubMed ID: 10381904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of electron-beam sterilized hemodialysis membranes and risk of thrombocytopenia.
    Kiaii M; Djurdjev O; Farah M; Levin A; Jung B; MacRae J
    JAMA; 2011 Oct; 306(15):1679-87. PubMed ID: 22009100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.